We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

LabMedica

Download Mobile App
Recent News Expo Clinical Chem. Molecular Diagnostics Hematology Immunology Microbiology Pathology Technology Industry Focus

MicroRNA Deficiency Points to Increased Lung Cancer Risk

By LabMedica International staff writers
Posted on 06 Nov 2013
A species of microRNA (miRNA) has been identified that acts as a regulator for the normal development of airway epithelial tissue but is less abundant in individuals, especially smokers, who had developed lung cancer.

MiRNAs are snippets of about 20 nucleotides that block gene expression by attaching to molecules of messenger RNA (mRNA) in a fashion that prevents them from transmitting the protein synthesizing instructions they had received from the DNA.

Investigators at the Boston University School of Medicine (MA, USA) used next-generation sequencing of small RNAs in the airway to identify microRNA 4423 (miR-4423) as a primate-specific miRNA associated with lung cancer. MiR-4423 was expressed primarily in the mucociliary epithelium.

Results of the study linked abundant levels of miR-4423 to normal cell growth and differentiation, while its lack was linked to cancer development. For example, the endogenous expression of miR-4423 increased as bronchial epithelial cells underwent differentiation into mucociliary epithelium in vitro, and its overexpression during this process caused an increase in the number of ciliated cells. Expression of miR-4423 was reduced in most lung tumors and in cytologically normal epithelium of the mainstem bronchus of smokers with lung cancer. In addition, expression of miR-4423 in a subset of lung cancer-cell lines reduced their anchorage-independent growth and significantly decreased the size of the tumors formed in a mouse xenograft model. Finally, overexpression of miR-4423 induced a differentiated-like pattern of airway epithelium-gene expression and reversed the expression of many genes that are altered in lung cancer.

"These results suggest measuring the levels of microRNAs like miR-4423 in cells that line the airway could aid in lung cancer detection through a relatively noninvasive procedure," said senior author Dr. Avrum Spira, professor of medicine at the Boston University School of Medicine.

The study was published in the October 24, 2013, online edition of the journal Proceedings of the National Academy of Sciences of the United States of America (PNAS).

Related Links:
Boston University School of Medicine



Gold Member
Nucleic Acid Extractor System
NEOS-96 XT
Online QC Software
Acusera 24•7
Immunofluorescence Analyzer
IFA System
CMV CLIA Diagnostic
CLIA CMV IgA Screen Group

Latest Pathology News

Uncertainty-Aware AI Tool Improves Digital Pathology for Cancer Subtyping
06 Nov 2013  |   Pathology

Study Highlights Biomarker Testing Delays in Lung Cancer Care
06 Nov 2013  |   Pathology

Stain-Free Imaging Platform Matches Standard Cancer Pathology
06 Nov 2013  |   Pathology



ADLM